Search results
Results From The WOW.Com Content Network
Frequency. 0.2% for those on biphosphonate type drugs >4 years. Medication-related osteonecrosis of the jaw ( MON, MRONJ) is progressive death of the jawbone in a person exposed to a medication known to increase the risk of disease, in the absence of a previous radiation treatment.
[12] [28]: 57 Finally, sleep disorders, coeliac disease, and side effects of medications may also explain symptoms. [12] Joint and muscle pain without swelling or inflammation is a common feature of ME/CFS, but is more closely associated with fibromyalgia. Modern definitions of fibromyalgia not only include widespread pain but also fatigue ...
Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis. [ 7][ 8] It has been found to decrease the risk of fractures of the spine. [ 7] Common side effects include headache, joint pain, and injection site reactions including pain. [ 7] It may increase the risk of heart attacks, strokes, and deaths from ...
James Paget. Paget's disease of bone (commonly known as Paget's disease or, historically, osteitis deformans) is a condition involving cellular remodeling and deformity of one or more bones. The affected bones show signs of dysregulated bone remodeling at the microscopic level, specifically excessive bone breakdown and subsequent disorganized ...
Raloxifene. Raloxifene, sold under the brand name Evista among others, is a medication used to prevent and treat osteoporosis in postmenopausal women and those on glucocorticoids. [ 5] For osteoporosis it is less preferred than bisphosphonates. [ 5] It is also used to reduce the risk of breast cancer in those at high risk. [ 5]
15% (50 year olds), 70% (over 80 year olds) [ 7] Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk. It is the most common reason for a broken bone among the elderly. [ 3]
What to know about menopause, according to a doctor. Menopause is a nearly universal experience for women who live to middle age. In the United States, an estimated 1.3 million women enter ...
Denosumab. Denosumab, sold under the brand names Prolia and Xgeva among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [ 8][ 9] Denosumab is contraindicated in people with low blood calcium levels.